2-Chloro-5-Iodobenzoic Acid CAS 19094-56-5 Empagliflozin Intermediate Assay ≥99.0% (HPLC)

ʻO ka wehewehe pōkole:

Inoa Kemika: 2-Chloro-5-Iodobenzoic Acid

CAS: 19094-56-5

ʻIke: ≥99.0% (HPLC)

ʻAno: Keʻokeʻo a i ʻole ʻeleʻele Melemele Crystal

ʻO Intermediate o Empagliflozin (CAS: 864070-44-0) no ka mālama ʻana i ka maʻi diabetes type 2

ʻO ke kūlana kiʻekiʻe, ka hana kālepa

Inquiry: alvin@ruifuchem.com

E hoʻouna i ka leka uila iā mākou

Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Mea Manufacturer Supply, High Purity, Commercial Production
Inoa Kemika: 2-Chloro-5-Iodobenzoic Acid
CAS: 19094-56-5

Na Waiwai Kemika:

Inoa Kimia	2-Chloro-5-Iodobenzoic Acid
Helu CAS	19094-56-5
Helu CAT	RF-PI438
Kūlana Kūʻai	Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā tona
ʻĀpana Molekala	C7H4ClIO2
Kaumaha Molecular	282.46
Ka hoʻoheheʻe	Hiki ke hoʻoheheʻe ʻia i ka Methanol
Brand	ʻO Ruifu Chemical

Nā kikoʻī:

'ikamu	Nā kikoʻī
Ka nana aku	Nā Kilika Melemele Keʻokeʻo
Hana ʻIke / ʻIke	≥99.0% (HPLC)
Lae hehee	161.0~163.0 ℃
Nalo ma ka maloo	≤0.50%
Koena ma ka Ignition	≤0.20%
Huina paumaele	≤1.0%
Metala Kaumaha	≤20ppm
Koena Solvent	Ethanol
Kūlana hoʻāʻo	ʻOihana Kūlana
Hoʻohana	Ka waena o Empagliflozin (CAS: 864070-44-0)

2-Chloro-5-Iodobenzoic Acid (CAS 19094-56-5) Alanui Synthetic

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai.

Pono:

FAQ:

Noi:

Hiki ke hoʻohana ʻia ka 2-Chloro-5-Iodobenzoic Acid (CAS: 19094-56-5) ma ke ʻano he lāʻau lapaʻau i ka synthesis o Empagliflozin (CAS: 864070-44-0).ʻO ka Empagliflozin (inoa kālepa ʻo Jardiance) he mea pale i ka sodium glucose co-transporter-2 (SGLT-2), a e hoʻoneʻe ʻia ke kō i loko o ke koko e nā puʻupaʻa a hoʻopau ʻia i loko o ka mimi.Ma ʻAukake 1, 2014, ua ʻae ka Food and Drug Administration (FDA) i ka lāʻau lapaʻau no ka mālama ʻana i ka maʻi maʻi type 2, e hoʻomaikaʻi a hoʻomalu i ka glucose koko o nā pākeke.ʻO Empagliflozin ke kolu o ka SGLT-2 mau lāʻau pale i ʻae ʻia e FDA.ʻElua mau lāʻau paʻa SGLT-2, ʻo Canagliflozin a me Dapagliflozin, nona ka Johnson Pharmaceuticals, AstraZeneca a me Bristol-Myers Squibb i ʻae ʻia e FDA i Nowemapa 2013 a me Ianuali 2014.